Clinically, elevated HOST2 expression has been associated with advanced tumor stage, lymph node or distant metastasis, and unfavorable overall survival in several cancer types, suggesting potential value as a prognostic biomarker and therapeutic target.
Qian-Wen Du, Ling-Yun Zhou, Dan Song et al.· Current molecular medicine· 0 citations
Evaluating FANCD2 expression and its clinical associations in PM and the effects of transient FANCD2 knockdown in NCI-H2052 cells demonstrated that FANCD2 was significantly upregulated in PM tissues relative to normal control samples, suggesting that FANCD2 may contribute to PM progression by supporting malignant pheno...
Ying-Fang Xiang, Pu Su, Rui-Ying Zhang et al.· Frontiers in Genetics· 0 citations
Malignant tumors remain a leading cause of global mortality, and the development of chemoresistance represents a major obstacle to effective cancer treatment. Long non-coding RNAs (lncRNAs) are important regulators of tumor progression and therapeutic response. Cancer susceptibility candidate 2 (CASC2) is an lncRNA tha...
Ling-Yun Zhou, Jin-Tao He, Wen-Bing Huang et al.· Journal of chemotherapy· 0 citations
GAS6-AS1 represents a promising molecule for understanding cancer pathogenesis and developing novel strategies for precision cancer diagnosis and treatment, although further clinical validation and mechanistic studies are still required.
Zhi-Ling Lu, Wen-Bing Huang, Jin-Tao He et al.· Biomedical Reports· 0 citations
Findings identify ADRB2 as a potential diagnostic and mechanistic target in asbestos-related PM and suggest that ADRB2 may contribute to crocidolite-induced malignant progression by modulating cellular responses associated with IL-17/NF-κB-related inflammatory signalling.
Shaoyang Huang, Dandan Gu, Jin-Tao He et al.· Chemico-Biological Interacti...· 0 citations
Preliminary mechanistic evidence is provided for further preclinical investigation of lycopene in PDAC, but its translational application will require optimized formulations, pharmacokinetic validation, and in vivo efficacy studies to overcome its limited bioavailability.
Shaoyang Huang, Dandan Gu, Dan Song et al.· Frontiers in Nutrition· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.